Active trachoma and ocular Chlamydia trachomatis infection in two Gambian regions: on course for elimination by 2020?
about
Where do we go from here? Prevalence of trachoma three years after stopping mass distribution of antibiotics in the regions of Kayes and Koulikoro, MaliMass treatment with azithromycin for trachoma: when is one round enough? Results from the PRET Trial in the GambiaAssociation between ocular bacterial carriage and follicular trachoma following mass azithromycin distribution in The GambiaNon-participation during azithromycin mass treatment for trachoma in The Gambia: heterogeneity and risk factorsCosts of testing for ocular Chlamydia trachomatis infection compared to mass drug administration for trachoma in the Gambia: application of results from the PRET studyThe Relationship between Active Trachoma and Ocular Chlamydia trachomatis Infection before and after Mass Antibiotic TreatmentCross-Sectional Surveys of the Prevalence of Follicular Trachoma and Trichiasis in The Gambia: Has Elimination Been Reached?Low Prevalence of Ocular Chlamydia trachomatis Infection and Active Trachoma in the Western Division of FijiComparing the performance of cluster random sampling and integrated threshold mapping for targeting trachoma control, using computer simulation.Follicular trachoma and trichiasis prevalence in an urban community in The Gambia, West Africa: is there a need to include urban areas in national trachoma surveillance?Haptoglobin and sickle cell polymorphisms and risk of active trachoma in Gambian children.Profound and sustained reduction in Chlamydia trachomatis in The Gambia: a five-year longitudinal study of trachoma endemic communitiesTrachoma prevalence and associated risk factors in the gambia and Tanzania: baseline results of a cluster randomised controlled trial.Design and baseline data of a randomized trial to evaluate coverage and frequency of mass treatment with azithromycin: the Partnership for Rapid Elimination of Trachoma (PRET) in Tanzania and The Gambia.Diagnostic accuracy of a prototype point-of-care test for ocular Chlamydia trachomatis under field conditions in The Gambia and Senegal.Pathway-focused arrays reveal increased matrix metalloproteinase-7 (matrilysin) transcription in trachomatous trichiasis.Characterization of Pgp3, a Chlamydia trachomatis plasmid-encoded immunodominant antigenThe conjunctival microbiome in health and trachomatous disease: a case control studyThe geographical distribution and burden of trachoma in Africa.Systemic effector and regulatory immune responses to chlamydial antigens in trachomatous trichiasis.What is causing active trachoma? The role of nonchlamydial bacterial pathogens in a low prevalence setting.Prevalence and associated factors of active trachoma among childeren aged 1-9 years in rural communities of Gonji Kolella district, West Gojjam zone, North West Ethiopia.Defining Seropositivity Thresholds for Use in Trachoma Elimination Studies.Can corneal pannus with trachomatous inflammation--follicular be used in combination as an improved specific clinical sign for current ocular Chlamydia trachomatis infection?Risk of Infection with Chlamydia trachomatis from Migrants to Communities Undergoing Mass Drug Administration for Trachoma Control.Health Beliefs and Perceptions of Trachoma in Communities on the Bijagos Archipelago of Guinea Bissau.Development and evaluation of a next-generation digital PCR diagnostic assay for ocular Chlamydia trachomatis infections.The epidemiological dynamics of infectious trachoma may facilitate elimination.Population-based prevalence survey of follicular trachoma and trachomatous trichiasis in the Casamance region of Senegal.Using a nonparametric multilevel latent Markov model to evaluate diagnostics for trachoma.HSV-2 enhances ZIKV infection of the placenta and induces apoptosis in first-trimester trophoblast cells.Stability of Chlamydia trachomatis on storage of dry swabs for accurate detection by nucleic acid amplification tests.Serology reflects a decline in the prevalence of trachoma in two regions of The Gambia.Current Research of Chlamydial Infection Diseases in China.
P2860
Q28474778-219CD1E2-903F-4FAA-BD84-67CC461E8CABQ28533873-3AF92FFB-BFCF-41FE-BBAF-E55DCF4F4EA8Q28534860-1ED489E4-1D03-49BF-9EF1-04F3DE7C3647Q28542612-EBE6263B-3674-42B3-A954-C5403A699856Q28546645-A6C5EE90-9CC7-43DF-8676-28D37FB821FAQ28552982-8DA35C52-2CA6-468E-87D6-A17B4937673BQ28554221-2E65D4B7-27E4-40C8-A173-FC14F7E92E5CQ28596379-077A55C8-11CD-408C-939E-A3CB7C136191Q31134167-0F0C4AA4-964F-4A1F-86C9-DD92D5328D88Q33605498-25965947-53F7-4B12-B6D3-E5B8D93DF0FEQ33605747-5ABC1C82-348B-43A5-BE82-EEC9F5839F3FQ33721962-425F2824-099F-4A68-9FCA-20563EBFDB1BQ33745187-9C1CBDBB-7303-4B93-9CC8-FB4E284341B8Q33806236-9904D970-E549-462C-8481-DCC2D9C190A4Q33988876-3512A8AE-1E75-493B-9FBA-742E9046971DQ34022544-BEACAF23-50C0-4061-8FAC-E1054BF88C2BQ34291171-702D7338-3ADC-44FC-905A-68E7054B15A5Q34636094-E0C3128E-4C11-4A6C-B843-0F25834C6237Q34952343-79C521A2-5FF4-4EFB-9A8E-0BFC7D25B2DFQ35084474-83C64B1D-80F9-494C-BA89-89B7B4A202BCQ35221283-37F1349C-6D2C-4DCE-822F-C666B77ADE2DQ35830966-740F1087-9D5B-4F90-AD75-C21F29887226Q36252526-BE989929-428B-4C77-90A2-0E51B544EEE9Q36508898-6988242D-3443-4B83-9676-903D3EB40D5FQ36640577-9A816F8F-1A30-4788-9F15-1A1DE23B0192Q36668534-B3E0E12C-F338-4DAC-891F-882278EF8DC2Q36971207-ADEAE470-F7DE-41C9-8062-49C5EC9A5D8FQ37407454-538E2952-F1C5-4538-8537-37100AAC2C0DQ37833738-8B7FB470-F15F-4F43-B77F-288C84F2DBA0Q37846762-B528C20A-0085-4473-8405-62486FE57215Q40054962-8206C289-F407-4EF7-9117-6610C90BC40EQ43225051-2DE223B2-DEB5-40AE-A5F1-C4B0A1957BA1Q43366299-0BF01C5C-89C6-4F25-992A-D25904BF06B8Q49940948-7548D584-F285-4662-99E2-E7182C2BE93F
P2860
Active trachoma and ocular Chlamydia trachomatis infection in two Gambian regions: on course for elimination by 2020?
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Active trachoma and ocular Chl ...... ourse for elimination by 2020?
@ast
Active trachoma and ocular Chl ...... ourse for elimination by 2020?
@en
Active trachoma and ocular Chl ...... ourse for elimination by 2020?
@nl
type
label
Active trachoma and ocular Chl ...... ourse for elimination by 2020?
@ast
Active trachoma and ocular Chl ...... ourse for elimination by 2020?
@en
Active trachoma and ocular Chl ...... ourse for elimination by 2020?
@nl
prefLabel
Active trachoma and ocular Chl ...... ourse for elimination by 2020?
@ast
Active trachoma and ocular Chl ...... ourse for elimination by 2020?
@en
Active trachoma and ocular Chl ...... ourse for elimination by 2020?
@nl
P2093
P2860
P50
P921
P1476
Active trachoma and ocular Chl ...... ourse for elimination by 2020?
@en
P2093
Ansumana Sillah
Esther Aryee
Isatou Sarr
Paul Snell
Sandra Molina
Tansy Edwards
P2860
P356
10.1371/JOURNAL.PNTD.0000573
P407
P5008
P577
2009-12-22T00:00:00Z